Novel approaches to identifying antiarrhythmic drugs
- PMID: 14596948
- DOI: 10.1016/j.tcm.2003.08.003
Novel approaches to identifying antiarrhythmic drugs
Abstract
Currently, device therapy with implantable cardioverter-defibrillators is the only proven effective therapy for sudden cardiac death. However, new insights into the mechanisms of ventricular fibrillation, particularly the role of dynamic factors that cause wave instability, are providing conceptual advances toward developing effective new pharmacotherapy.
Similar articles
-
A novel approach to identifying antiarrhythmic drug targets.Drug Discov Today. 2003 Feb 15;8(4):162-7. doi: 10.1016/s1359-6446(02)02567-9. Drug Discov Today. 2003. PMID: 12581710 Review.
-
Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.Am J Cardiovasc Drugs. 2005;5(6):371-8. doi: 10.2165/00129784-200505060-00004. Am J Cardiovasc Drugs. 2005. PMID: 16259525 Review.
-
The role of pharmacotherapy in the prevention of sudden cardiac death in patients with heart failure.Heart Fail Rev. 2016 Jul;21(4):415-31. doi: 10.1007/s10741-016-9546-7. Heart Fail Rev. 2016. PMID: 27003591 Review.
-
New approaches for identifying antiarrhythmic drug targets.Expert Opin Ther Targets. 2004 Feb;8(1):1-5. doi: 10.1517/14728222.8.1.1. Expert Opin Ther Targets. 2004. PMID: 14996613
-
Ventricular fibrillation: new insights into mechanisms.Ann N Y Acad Sci. 2004 May;1015:122-32. doi: 10.1196/annals.1302.010. Ann N Y Acad Sci. 2004. PMID: 15201154 Review.
Cited by
-
A simulation study of the effects of cardiac anatomy in ventricular fibrillation.J Clin Invest. 2004 Mar;113(5):686-93. doi: 10.1172/JCI17341. J Clin Invest. 2004. PMID: 14991066 Free PMC article.
-
Systems-based approaches to cardiovascular disease.Nat Rev Cardiol. 2012 Jan 10;9(3):172-84. doi: 10.1038/nrcardio.2011.208. Nat Rev Cardiol. 2012. PMID: 22231714 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources